257 related articles for article (PubMed ID: 17655675)
1. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
2. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome.
Erdogan O; Aksoy A; Turgut N; Durusoy E; Samsa M; Altun A
J Electrocardiol; 2008; 41(4):325-8. PubMed ID: 18353348
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
5. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
6. Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia.
Fernández M; Marín MDR; Fernández-Armenta J; Mora-López F; Fernández Rivero R; Berruezo A; Cano Calabria L; Vázquez García R
Pacing Clin Electrophysiol; 2018 Apr; 41(4):429-432. PubMed ID: 29023786
[No Abstract] [Full Text] [Related]
7. Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.
Fox DJ; Klein GJ; Hahn A; Skanes AC; Gula LJ; Yee RK; Subbiah RN; Krahn AD
Europace; 2008 Aug; 10(8):1006-8. PubMed ID: 18621769
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
[TBL] [Abstract][Full Text] [Related]
9. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
10. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
Sato A; Takano T; Chinushi M; Minamino T
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
[TBL] [Abstract][Full Text] [Related]
11. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
12. Effect of flecainide on T-wave alternans in Andersen-Tawil syndrome.
Hayashi H; Kawaguchi T; Horie M
Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):383-6. PubMed ID: 25040481
[No Abstract] [Full Text] [Related]
13. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent rhythmic cardiomyopathy secondary to idiopathic ventricular tachycardia].
Henrard V; Piérard LA
Arch Mal Coeur Vaiss; 2001 Jun; 94(6):617-21. PubMed ID: 11480161
[TBL] [Abstract][Full Text] [Related]
15. Failure of radiofrequency catheter ablation and success of flecainide to suppress premature ventricular contractions in Andersen-Tawil syndrome: A case report.
Yilmaz S; Kanat S
J Electrocardiol; 2021; 68():37-40. PubMed ID: 34311212
[TBL] [Abstract][Full Text] [Related]
16. Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.
Hong RA; Rivera KK; Jittirat A; Choi JJ
Pacing Clin Electrophysiol; 2012 Jul; 35(7):794-7. PubMed ID: 22553997
[TBL] [Abstract][Full Text] [Related]
17. Cardiac surgery for a patient with Andersen-Tawil syndrome.
Nagashima M; Higaki T; Seike Y; Yokoyama Y
Ann Thorac Surg; 2010 Jul; 90(1):285-7. PubMed ID: 20609799
[TBL] [Abstract][Full Text] [Related]
18. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.
Kim JB; Chung KW
Pediatr Neurol; 2009 Dec; 41(6):464-6. PubMed ID: 19931173
[TBL] [Abstract][Full Text] [Related]
19. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
20. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
